Nicole Mowad-Nassar
Vermogen: 186 558 $ op 31-08-2026
Vermogen: 186 558 $ op 31-08-2026
Nicole Mowad-Nassar is currently an Independent Non-Executive Director at ResMed, Inc. since 2025 and Vice President-Marketing at Takeda Pharmaceuticals U.S.A., Inc. Formerly, Ms. Mowad-Nassar was Senior Vice President & President-Specialty at AbbVie, Inc. from 2023 to 2025.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 22-09-2026 | 777 ( 0% ) | 186 558 $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| RESMED, INC. | Directeur/Bestuurslid | 15-08-2025 |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Verkoop & Marketing | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| ABBVIE INC. | Corporate Officer/Principal | 01-09-2025 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
ResMed, Inc.
ResMed, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and markets devices for evaluation and treatment of sleep disorders | Health Technology |
AbbVie, Inc.
AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau